Literature DB >> 7160376

Bile-salt-binding polypeptides in plasma membranes of hepatocytes revealed by photoaffinity labelling.

W Kramer, U Bickel, H P Buscher, W Gerok, G Kurz.   

Abstract

1. Photoaffinity labelling of a subfraction of plasma membranes of rat liver, enriched with sinusoidal surfaces, with the sodium salts of (3 beta-azido-7 alpha,12 alpha-dihydroxy-5 beta-cholan-24-oyl)-2-amino[2-3H(N)]ethanesulfonic acid, (7,7-azo-3 alpha,12 alpha-dihydroxy-5 beta-cholan-24-oyl)-2-amino[2-3H(N)]ethanesulfonic acid and (11 xi-azido-12-oxo-3 alpha,7 alpha-dihydroxy- 5 beta-cholan-24-oyl)-2-amino[2-3H(N)]ethanesulfonic acid resulted with each derivative in a clear covalent incorporation of radioactivity into polypeptides with the apparent molecular weights of 67,000, 52,000, 48,000, 43,000 and about 20,000. 2. Photoaffinity labelling of a membrane subfraction predominantly composed of bile canalicular membranes by the photolabile derivatives of the conjugated bile salts also showed covalent incorporation of radioactivity into polypeptides of the same apparent molecular weights as with the subfraction enriched with the sinusoidal membranes. 3. The extent of photoaffinity labelling of the different membrane polypeptides is dependent upon the photolabile bile-salt derivative used. However, with each of the photolabile derivatives the relative ratio of the labelling of the different membrane polypeptides was similar for both membrane subfractions. Provided that the uptake as well as the secretion of bile salts by hepatocytes are carrier-mediated processes, this suggests the participation of the same polypeptides in both processes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7160376     DOI: 10.1111/j.1432-1033.1982.tb07015.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  16 in total

Review 1.  Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.

Authors:  Michael S Roberts; Beatrice M Magnusson; Frank J Burczynski; Michael Weiss
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Properties of phallotoxin uptake by basolateral plasma membrane vesicles from rat liver: evidence for a carrier-mediated transport.

Authors:  M Täfler; K Ziegler; M Frimmer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-02       Impact factor: 3.000

Review 3.  Carrier-mediated transport in the hepatic distribution and elimination of drugs, with special reference to the category of organic cations.

Authors:  D K Meijer; W E Mol; M Müller; G Kurz
Journal:  J Pharmacokinet Biopharm       Date:  1990-02

Review 4.  Biochemistry of bile secretion.

Authors:  R Coleman
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

5.  Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes.

Authors:  B Hagenbuch; B F Scharschmidt; P J Meier
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

Review 6.  Organic anion uptake by hepatocytes.

Authors:  Allan W Wolkoff
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

7.  Functional reconstitution of the canalicular bile salt transport system of rat liver.

Authors:  S Ruetz; G Hugentobler; P J Meier
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

8.  Anion transport in basolateral (sinusoidal) liver plasma-membrane vesicles of the little skate (Raja erinacea).

Authors:  G Hugentobler; G Fricker; J L Boyer; P J Meier
Journal:  Biochem J       Date:  1987-11-01       Impact factor: 3.857

9.  Properties of iodipamide uptake by isolated rat hepatocytes.

Authors:  C Joppen; E Petzinger; M Frimmer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-12       Impact factor: 3.000

10.  Identity of hepatic membrane transport systems for bile salts, phalloidin, and antamanide by photoaffinity labeling.

Authors:  T Wieland; M Nassal; W Kramer; G Fricker; U Bickel; G Kurz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.